Article ID Journal Published Year Pages File Type
10964866 Vaccine 2015 5 Pages PDF
Abstract
These post-marketing surveillance data suggest a good safety profile for JE-VC consistent with findings from pre-licensure clinical trials. Post-licensure safety data should continue to be monitored for any evidence of rare serious or neurologic adverse events.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , ,